Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Patient-to-patient transmission of KPC variants with reduced ceftazidime-avibactam susceptibility.

Munoz-Price LS, Reeme AE, Buchan BW, Mettus RT, Mustapha MM, Van Tyne D, Shields RK, Doi Y.

Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00955-19. doi: 10.1128/AAC.00955-19. [Epub ahead of print]

PMID:
31332070
2.

Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258.

Iovleva A, Mettus RT, McElheny CL, Mustapha MM, Van Tyne D, Shields RK, Pasculle AW, Cooper VS, Doi Y.

J Antimicrob Chemother. 2019 Aug 1;74(8):2203-2208. doi: 10.1093/jac/dkz183.

PMID:
31127290
3.

Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreak.

Reeme AE, Bowler SL, Buchan BW, Graham MB, Behrens E, Singh S, Hong JC, Arvan J, Hyke JW, Palen L, Savage S, Seliger H, Huerta S, Ledeboer NA, Kotay S, Mathers AJ, Cooper VS, Mustapha MM, Mettus RT, Doi Y, Munoz-Price LS.

Infect Control Hosp Epidemiol. 2019 Jul;40(7):767-773. doi: 10.1017/ice.2019.99. Epub 2019 May 14.

PMID:
31084655
4.

Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae.

Wilson WR, Kline EG, Jones CE, Morder KT, Mettus RT, Doi Y, Nguyen MH, Clancy CJ, Shields RK.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02048-18. doi: 10.1128/AAC.02048-18. Print 2019 Mar.

5.

A Prospective Study of Acinetobacter baumannii Complex Isolates and Colistin Susceptibility Monitoring by Mass Spectrometry of Microbial Membrane Glycolipids.

Leung LM, McElheny CL, Gardner FM, Chandler CE, Bowler SL, Mettus RT, Spychala CN, Fowler EL, Opene BNA, Myers RA, Goodlett DR, Doi Y, Ernst RK.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01100-18. doi: 10.1128/JCM.01100-18. Print 2019 Mar.

6.

Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.

Hakki M, Humphries RM, Hemarajata P, Tallman GB, Shields RK, Mettus RT, Doi Y, Lewis JS.

Clin Infect Dis. 2019 May 30;68(12):2045-2052. doi: 10.1093/cid/ciy825.

PMID:
30256922
7.

Diversity of High-Level Aminoglycoside Resistance Mechanisms among Gram-Negative Nosocomial Pathogens in Brazil.

Ballaben AS, Andrade LN, Galetti R, Ferreira JC, McElheny CL, Mettus RT, da Silva P, de Oliveira Garcia D, Darini ALC, Doi Y.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01550-18. doi: 10.1128/AAC.01550-18. Print 2018 Nov. No abstract available.

8.

Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii.

Mustapha MM, Li B, Pacey MP, Mettus RT, McElheny CL, Marshall CW, Ernst RK, Cooper VS, Doi Y.

J Antimicrob Chemother. 2018 Nov 1;73(11):2952-2959. doi: 10.1093/jac/dky290.

PMID:
30124845
9.

Absence of fosfomycin resistance in gastrointestinal Escherichia coli following fosfomycin therapy.

Mettus RT, Bowler SL, Kantz SF, McElheny CL, Pasculle AW, Doi Y.

J Glob Antimicrob Resist. 2018 Sep;14:109-110. doi: 10.1016/j.jgar.2018.06.015. Epub 2018 Jun 30. No abstract available.

PMID:
29969752
10.

Draft Genome Sequences of blaKPC-Containing Enterobacter aerogenes, Citrobacter freundii, and Citrobacter koseri Strains.

Hazen TH, Mettus RT, McElheny CL, Bowler SL, Doi Y, Rasko DA.

Genome Announc. 2018 Feb 22;6(8). pii: e00035-18. doi: 10.1128/genomeA.00035-18.

11.

Origin of the plasmid-mediated fosfomycin resistance gene fosA3.

Ito R, Pacey MP, Mettus RT, Sluis-Cremer N, Doi Y.

J Antimicrob Chemother. 2018 Feb 1;73(2):373-376. doi: 10.1093/jac/dkx389.

12.

Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.

Lucas AE, Ito R, Mustapha MM, McElheny CL, Mettus RT, Bowler SL, Kantz SF, Pacey MP, Pasculle AW, Cooper VS, Doi Y.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01368-17. doi: 10.1128/JCM.01368-17. Print 2018 Jan.

13.

Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.

Ito R, Tomich AD, McElheny CL, Mettus RT, Sluis-Cremer N, Doi Y.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01424-17. doi: 10.1128/AAC.01424-17. Print 2017 Dec.

14.

Structural modification of LPS in colistin-resistant, KPC-producing Klebsiella pneumoniae.

Leung LM, Cooper VS, Rasko DA, Guo Q, Pacey MP, McElheny CL, Mettus RT, Yoon SH, Goodlett DR, Ernst RK, Doi Y.

J Antimicrob Chemother. 2017 Nov 1;72(11):3035-3042. doi: 10.1093/jac/dkx234.

15.

Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene.

Ito R, Mustapha MM, Tomich AD, Callaghan JD, McElheny CL, Mettus RT, Shanks RMQ, Sluis-Cremer N, Doi Y.

MBio. 2017 Aug 29;8(4). pii: e00749-17. doi: 10.1128/mBio.00749-17.

16.

Contribution of the TetB Efflux Pump to Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii Strains.

Wang P, McElheny CL, Mettus RT, Shanks RMQ, Doi Y.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01176-17. doi: 10.1128/AAC.01176-17. Print 2017 Oct. No abstract available.

17.

Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens.

Liu YY, Chandler CE, Leung LM, McElheny CL, Mettus RT, Shanks RMQ, Liu JH, Goodlett DR, Ernst RK, Doi Y.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00580-17. doi: 10.1128/AAC.00580-17. Print 2017 Jun.

18.

Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Citrobacter freundii at a Tertiary Acute Care Facility in Miami, Florida.

Jiménez A, Castro JG, Munoz-Price LS, de Pascale D, Shimose L, Mustapha MM, Spychala CN, Mettus RT, Cooper VS, Doi Y.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):320-326. doi: 10.1017/ice.2016.273. Epub 2016 Dec 7.

PMID:
27923418
19.

Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.

Wang P, Bowler SL, Kantz SF, Mettus RT, Guo Y, McElheny CL, Doi Y.

J Clin Microbiol. 2016 Dec;54(12):2937-2941. Epub 2016 Sep 14.

20.

In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains.

Bowler SL, Spychala CN, McElheny CL, Mettus RT, Doi Y.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5101. doi: 10.1128/AAC.01124-16. Print 2016 Aug. No abstract available.

Supplemental Content

Loading ...
Support Center